Matinas BioPharma receives NYSE noncompliance notice
[ad_1]
Matinas BioPharma receives NYSE noncompliance notice
[ad_2]
Similar Posts
Indaptus Therapeutics looks to raise $2.25M in private placement
Byadmin
[ad_1] Indaptus Therapeutics looks to raise $2.25M in private placement [ad_2]
OS Therapies up 65% as lung osteosarcoma asset meets goal in phase 2 trial
Byadmin
[ad_1] Nemes Laszlo/iStock via Getty Images OS Therapies (NYSE:OSTX) is up ~65% in premarket trading Wednesday after releasing phase 2b data on OST-HER2 for prevention of recurrent, fully resected, lung metastatic osteosarcoma. Results indicated that the candidate met its primary endpoint of 12-month event-free survival. OST-HER2 had [ad_2]
SailPoint Parent files for $100M IPO
Byadmin
[ad_1] SailPoint Parent files for $100M IPO [ad_2]
Digital Realty Trust raised to Buy as UBS sees accelerating growth
Byadmin
[ad_1] Digital Realty Trust raised to Buy as UBS sees accelerating growth [ad_2]
Hisense Lifts the Lifestyles Bar at GITEX Global 2023 With ‘Go Tech & Beyond’
Byadmin
[ad_1] PRWire: Lifestyles Made Easy as Global Electronics Leader Gets Super Smart Appliances and state of the art, premium home entertainment solutions. Visitors To Get Preview of ULED X, the masterpiece in Television as well as Intelligent Refrigerators and Washing Machines. Dubai, UAE, October 16, 2023: Global electronics leader Hisense is looking to transform Middle…
SPDR SSGA Income Allocation ETF declares quarterly distribution of $0.5017
Byadmin
[ad_1] SPDR SSGA Income Allocation ETF declares quarterly distribution of $0.5017 [ad_2]